Fuwai Hospital, Chinese Academy of Medical Sciences (Fuwai Hospital, CAMS & PUMC)
Fuwai Hospital, Chinese Academy of Medical Sciences (Fuwai Hospital, CAMS & PUMC) — Beijing
Hospital Profile
Fuwai Hospital, Chinese Academy of Medical Sciences, was established in 1956. In 2009, it was approved to establish the National Center for Cardiovascular Diseases, forming an integrated "center-hospital" structure. It is a national tertiary A-level specialized hospital for cardiovascular diseases, the site of the National Clinical Research Center for Cardiovascular Diseases and the National Key Laboratory for Cardiovascular Diseases, and also the largest cardiovascular disease diagnosis and treatment center in the world. In the "China Best Hospital Specialty Reputation Rankings," the cardiovascular disease and cardiac surgery departments have ranked first for nine consecutive years; in the China Hospital Science and Technology Influence Ranking, the cardiovascular specialty has ranked first for five consecutive years. The hospital has six academicians and 21 experts with outstanding contributions at the national and provincial/ministerial levels. It has won 43 National Science and Technology Progress Awards and is known as a cradle for talent cultivation in the field of cardiovascular disease prevention and treatment in China.
Medical Milestones
Founded in 1956; in 1959, it took the lead in conducting epidemiological research on hypertension and organized multiple national sampling surveys; in 1969, it went deep into Shougang to develop the 'Shougang Model' (promoted globally by WHO in 1994); in 1978, it established China's first cardiovascular epidemiology research laboratory; carried out the country's first ventricular aneurysm resection, coronary artery bypass surgery, mechanical and biological valve replacement, as well as the first domestic/international complex heart surgeries and conversions; in recent years, it conducted the country's first clinical trial of implantable artificial hearts, domestically developed third-generation fully magnetically suspended artificial hearts, Asia's first percutaneous left ventricular assist device (Impella), the country's first leadless pacemaker implantation, and pioneered multiple one-stop hybrid techniques and the world's first 3D-printed percutaneous inferior vena cava type atrial septal defect closure; in 2017, it was entrusted to establish the National Cardiovascular Disease Professional Quality Control Center.
Key Capabilities & Patient Care
There are 35 wards and 20 clinical centers. In 2018, the outpatient visits exceeded 744,000, and discharges exceeded 69,000 (with a mortality rate of only 0.2%). There were more than 14,400 inpatient surgical procedures and 49,000 interventional procedures in internal medicine. Multiple indicators such as average length of stay for discharged patients (6.8 days), outcomes, surgical mortality, and bed turnover rate ranked first among specialty hospitals nationwide. A prevention and control network covering 25 provinces/municipalities has been established (managing 600,000 patients); it leads the 'Early Screening and Comprehensive Intervention Project for High-Risk Cardiovascular Populations' (establishing the world's largest prospective cohort of one million people); and has set up a national primary hypertension management office (online training covers 930,000 primary care doctors). It undertakes the 'Yunnan Project' and 'Henan Project' (establishing Fuwai Hospital in Yunnan and Fuwai Huazhong Cardiovascular Hospital).
Advanced Technology
Equipped with medical devices such as angiography machines, dual-source CT, MRI, and PET-CT; developed a visualized surgery platform, automatic clothing dispensing system, and intelligent medicine cabinet; houses two national key laboratories, including the National Key Laboratory of Cardiovascular Diseases and the National Clinical Research Center for Cardiovascular Diseases, two ministerial-level key laboratories, and two Beijing municipal key laboratories; established a cardiovascular biobank sharing platform and a molecular diagnostics center. Statistics: • Bed capacity: authorized 1,521 beds, 1,279 beds actually open (2020) • Total staff: 3,571 (2020) • Inpatients: 74,500 discharges (2019) • Outpatient and emergency visits: 801,000 outpatient + 32,000 emergency (2019) • Inpatient and elective surgeries: 14,800 surgical + 52,700 interventional procedures (2019) • Number of senior physicians: official total not disclosed; estimated around 429–571 people (this is an estimate, not official data, calculated as 3,571 staff × 12%–16%)
International Patient Services
Established collaborations with the Cleveland Clinic in the United States, the University of Oxford in the United Kingdom, and others; hosted nearly 10,000 foreign guests from over 100 countries and regions for exchanges, conducted demonstration teaching with more than 30 countries; received medical staff from Indonesia, Egypt, and other countries for training at the hospital. (No specific services of the independent special needs department/international department mentioned)